Mark J. Ratain - Concepedia

Author

Mark J. Ratain

University of Chicago

Also Known As

Kosorok, Michael, M J Ratain, M. Ratain, Mark J Ratain, Mark J. Ratain

Publications

825

Citations

H-Index

Concepts

All Affiliations

University of Chicago City Of Hope National Medical Center

About

Mark J. Ratain is an author at University of Chicago specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	100
2	Public Health	1	1	24
3	Biostatistics	1	1	43
4	Obstetrics	1	1	24
5	Pathology	1	1	24

Mark J. Ratain

Publications

418

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicin Stephen P. Ackland, Mark J. Ratain, Nicholas J. Vogelzang, Clinical Pharmacology & Therapeutics	1989	89
Paradoxical relationship between acetylator phenotype and amonafide toxicity Mark J. Ratain, Rosemarie Mick, F Berezin, Clinical Pharmacology & Therapeutics	1991	81
A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer Everett E. Vokes, Richard L. Schilsky, Choi Kyung E., Cancer	1989	46
Modeling Interpatient Pharmacodynamic Variability of Etoposide Rosemarie Mick, Mark J. Ratain JNCI Journal of the National Cancer Institute Precision DosingMolecular PharmacologyTranslational MedicinePharmacokinetic ModelingPhysiologically-based Pharmacokinetic Modeling	1991	43
Granulocyte-macrophage-colony stimulating factor in metastatic renal cell carcinoma Brian I. Rini, Walter M. Stadler, Ricardo Spielberger, Cancer	1998	40
A Phase I Study of Liposomal Doxorubicin (Doxil) With Topotecan Christopher W. Ryan, Gini F. Fleming, Linda Janisch, American Journal of Clinical Oncology	2000	27
Conservative management of primary cervical lymphoma using combination chemotherapy: A case report Carolyn Johnston, Elizabeth K. Senekjian, Mark J. Ratain, Gynecologic Oncology Lymphoid NeoplasiaCervical Cancer ManagementCervical CancerCombination ChemotherapyMedicine	1989	24
Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer. Rod Humerickhouse, M. Eileen Dolan, Daniel J. Haraf, PubMed Advanced HeadRadiation MedicineNeck CancerRadiation TherapyMedicine	1999	23
A phase I study of subcutaneous recombinant interleukin-2 and interferon alfa-2a Mark J. Ratain, Edwin R. Priest, Linda Janisch, Cancer	1993	20
A phase I study of intermittent infusion cladribine in patients with solid tumors Nicholas J. Vogelzang, Sheila M. O'Brien, Richard L. Schilsky, Cancer	1994	15

Page 1